Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Responses closed . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM CDT
- Posted
- May 7, 2026
- Notice type
- Solicitation
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- DEFENSE HEALTH AGENCY (DHA)
- Place of performance
- San Antonio, Texas, 78230
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- HT9402-26-Q-9302
- Notice ID
- cc93cf8ed0774bebbc781e5999c79061
Description
The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.
P&T COMMITTEE MEETING: The following May 2026 newly approved drugs will be reviewed:
a. Lifyorli - Oncological Agents - Glucocorticoid Receptor Antagonist
b. Quiofic - VITAMINS - WATER SOLUBLE
c. Widaplik - ANTIHYPERTENSIVE AGENTS – N/A
d. Saphnelo – IMMUNOSUPPRESSIVES – N/A
The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9302.
Pre-quotation teleconference is on May 13, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (9)
- Download
Amendment 1 HT9402-26-Q-9302 . A0001.pdf
139 KBAdded in Solicitation version 2Posted - Download
A-3 RFQ HT9402-26-Q-9302 . A0001.pdf
793 KBAdded in Solicitation version 2Posted - Download
A-3 RFQ HT9402-26-Q-9302.pdf
793 KBAdded in Solicitation version 1Posted - Download
A-3 Price List - Widaplik - Antihypertensive Agents-NA.xlsx
45 KBAdded in Solicitation version 1Posted - Download
A-3 Price List - Lifyorli - Oncological Agents - Glucocorticoid Receptor Antagonist.xlsx
45 KBAdded in Solicitation version 1Posted - Download
A-3 Price List - Saphnelo - Immunosuppressives - NA.xlsx
45 KBAdded in Solicitation version 1Posted - Download
A-3 Price List - Quiofic - Vitamins - Water Soluble.xlsx
44 KBAdded in Solicitation version 1Posted - Download
A-3 Price Appendix FAQ NAD.pdf
231 KBAdded in Solicitation version 1Posted - Download
A-3 DoD Formulary Placement of FDA Newly Approved Drugs.pdf
83 KBAdded in Solicitation version 1Posted
Links (1)
- https://health.mil/PandThealth.milPosted
Lifecycle
- 1Version 1Solicitation
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
- 2Version 2SolicitationCurrent
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
HT9402-26-Q-9302
Archive Date
Nov 28, 2026
Office Address
JBSA FT SAM HOUSTON, TX, 78234